Loading clinical trials...
Loading clinical trials...
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
Conditions
Interventions
Pentosan Polysulfate Sodium twice weekly
Placebo (Sodium Chloride Injection, 0.9%)
+2 more
Locations
33
United States
Alliance for Multispecialty Research - Tempe
Tempe, Arizona, United States
Fiel Family and Sports Medicine
Tempe, Arizona, United States
Tucson Orthopaedic Institute
Tucson, Arizona, United States
Core Healthcare Group
Cerritos, California, United States
Biosolutions Clinical Research Center
La Mesa, California, United States
Providence Clinical Research
North Hollywood, California, United States
Start Date
October 19, 2021
Primary Completion Date
October 15, 2024
Completion Date
January 6, 2025
Last Updated
April 8, 2024
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Paradigm Biopharmaceuticals USA (INC)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions